RNA modulators of complex phenotypes in mammalian cells

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Lai, Angela ^a,c   Cairns, Murray J ^a,d   Tran, Nham ^a,b   Zhang, Hong Ping ^a   Cullen, Lara ^a,c   Arndt, Greg M ^a  

^a JOHNSON AND JOHNSON   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Applied Biosystems   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; FLUOROURACIL; RETROVIRUS VECTOR; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC ANTIMETABOLITE; DNA DIRECTED RNA POLYMERASE III; PROTEIN P53; TP53 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL DEATH; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PHENOTYPE; PROMOTER REGION; RNA INTERFERENCE; COLORECTAL TUMOR; DRUG EFFECT; DRUG RESISTANCE; GENE LIBRARY; GENETICS; METABOLISM; RETROVIRUS; TUMOR CELL CULTURE; WESTERN BLOTTING;

MAMMALIA;

ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL DEATH; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE LIBRARY; HUMANS; PHENOTYPE; PROMOTER REGIONS, GENETIC; RETROVIRIDAE; RNA POLYMERASE III; RNA, COMPLEMENTARY; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 62749186114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004758     Document Type: Article

References (50)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
2. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200.
3. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
4. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A 98: 9742-9747.
5. Paul CP, Good PD, Winer I, Engelke DR (2002) Effective expression of small interfering RNA in human cells. Nat Biotechnol 20: 505-508.
6. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
7. Miyagishi M, Taira K (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20: 497-500.
8. Wang Z, Morris JC, Drew ME, Englund PT (2000) Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem 275: 40174-40179.
9. Giordano E, Rendina R, Peluso I, Furia M (2002) RNAi triggered by symmetrically transcribed transgenes in Drosophila melanogaster. Genetics 160: 637-648.
10. Tran N, Cairns MJ, Dawes IW, Arndt GM (2003) Expressing functional siRNAs in mammalian cells using convergent transcription. BMC Biotechnol 3: 21.
11. Kaykas A, Moon RT (2004) A plasmid-based system for expressing small interfering RNA libraries in mammalian cells. BMC Cell Biol 5: 16.
12. Boutros M, Ahringer J (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9: 554-566.
13. Wolters NM, MacKeigan JP (2008) From sequence to function: using RNAi to elucidate mechanisms of human disease. Cell Death Differ 15: 809-819.
14. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, et al. (2000) Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408: 325-330.
15. Kiger AA, Baum B, Jones S, Jones MR, Coulson A, et al. (2003) A functional genomic analysis of cell morphology using RNA interference. J Biol 2: 27.
16. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428: 431-437.
17. Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, et al. (2004) A resource for large-scale RNA-interference-based screens in mammals. Nature 428: 427-431.
18. Silva JM, Li MZ, Chang K, Ge W, Golding MC, et al. (2005) Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37: 1281-1288.
19. Luo B, Heard AD, Lodish HF (2004) Small interfering RNA production by enzymatic engineering of DNA (SPEED). Proc Natl Acad Sci U S A 101: 5494-5499.
20. Shirane D, Sugao K, Namiki S, Tanabe M, Iino M, et al. (2004) Enzymatic production of RNAi libraries from cDNAs. Nat Genet 36: 190-196.
21. Sen G, Wehrman TS, Myers JW, Blau HM (2004) Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nat Genet 36: 183-189.
22. Zheng L, Liu J, Batalov S, Zhou D, Orth A, et al. (2004) An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci U S A 101: 135-140.
23. Zhang JZ, Gao W, Yang HB, Zhang B, Zhu ZY, et al. (2006) Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library. Stem Cells 24: 2661-2668.
24. Jian R, Cheng X, Jiang J, Deng S, Hu F, et al. (2007) A cDNA-based random RNA interference library for functional genetic screens in embryonic stem cells. Stem Cells 25: 1904-1912.
25. Wu H, Dinh A, Mo YY (2007) Generation of shRNAs from randomized oligonucleotides. Biol Proced Online 9: 9-17.
26. Guo Q, Kong Y, Fu L, Yu T, Xu J, et al. (2007) A randomized lentivirus shRNA library construction. Biochem Biophys Res Commun 358: 272-276.
27. Gou D, Zhang H, Baviskar PS, Liu L (2007) Primer extension-based method for the generation of a siRNA/miRNA expression vector. Physiol Genomics 31: 554-562.
28. Wang Y, Wang YE, Cotticelli MG, Wilson RB (2008) A random shRNA-encoding library for phenotypic selection and hit-optimization. PLoS ONE 3: e3171.
29. Chen M, Zhang L, Zhang HY, Xiong X, Wang B, et al. (2005) A universal plasmid library encoding all permutations of small interfering RNA. Proc Natl Acad Sci U S A 102: 2356-2361.
30. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, et al. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
31. Worthington MT, Pelo J, Lo RQ (2001) Cloning of random oligonucleotides to create single-insert plasmid libraries. Anal Biochem 294: 169-175.
32. Flynt AS, Lai EC (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 9: 831-842.
33. Szell M, Bata-Csorgo Z, Kemeny L (2008) The enigmatic world of mRNA-like ncRNAs: their role in human evolution and in human diseases. Semin Cancer Biol 18: 141-148.
34. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21: 635-637.
35. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
36. Saxena S, Jonsson ZO, Dutta A (2003) Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278: 44312-44319.
37. Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z (2005) A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res 33: 1671-1677.
38. Dahlgren C, Zhang HY, Du Q, Grahn M, Norstedt G, et al. (2008) Analysis of siRNA specificity on targets with double-nucleotide mismatches. Nucleic Acids Res 36: e53.
39. Amarzguioui M, Holen T, Babaie E, Prydz H (2003) Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31: 589-595.
40. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
41. Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, et al. (2006) Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. Rna 12: 1179-1187.
42. Anderson EM, Birmingham A, Baskerville S, Reynolds A, Maksimova E, et al. (2008) Experimental validation of the importance of seed complement frequency to siRNA specificity. Rna 14: 853-861.
43. Schmidt WM, Kalipciyan M, Dornstauder E, Rizovski B, Steger GG, et al. (2004) Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int J Cancer 112: 200-212.
44. De Angelis PM, Svendsrud DH, Kravik KL, Stokke T (2006) Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 5: 20.
45. Guo X, Goessl E, Jin G, Collie-Duguid ES, Cassidy J, et al. (2008) Cell cycle perturbation and acquired 5-fluorouracil resistance. Anticancer Res 28: 9-14.
46. Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G (2004) Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp Cell Res 293: 311-320.
47. Puca R, Nardinocchi L, Pistritto G, D'Orazi G (2008) Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol 109: 403-410.
48. Nardinocchi L, Puca R, Sacchi A, D'Orazi G (2009) Inhibition of HIF-1α activity by homoeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis. Mol Cancer 8: 1.
49. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
50. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, et al. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol 157: 411-421.